A "new frontier" for in-clinic veterinary cancer screeningJuly 7, 2025Cancer screening can be a stressful time for clients. However, deep learning artificial intelligence (AI) is changing the game for cytology. AI Masses – a new addition to Zoetis’s Vetscan Imagyst® platform – offers veterinarians analysis of potentially cancerous cells at the point of care, for more timely and individualized diagnosis and treatment.
SPONSORED CONTENTAre Your Patients Fully Protected?Fleas, ticks, heartworms, and intestinal parasites—dogs face multiple threats. See how a multi-parasite approach can offer your patients a broad range of protection. + Learn More
Demystifying cancer screening and detectionFebruary 21, 2024Before we can broadly incorporate these tests into our clinical practice, we need to understand how they work, consider the evidence behind them.
Blood test streamlines canine cancer detectionDecember 9, 2020Texas A&M has introduced a simplified oncology test that allows for early diagnosis in dogs.
